Check out our 15-minute presentation on the revolutionary impact of ADCs in targeted cancer therapy. Detailing their journey from conception to becoming a leading treatment modality, we highlight the significant bioanalytical challenges and regulatory milestones that shape ADC development.
What you will learn:
The components of ADCs and their roles in targeting and killing tumor cells
Bioanalytical details on PK, PD, immunogenicity, receptor occupancy and immunotoxicity studies
Analytical platforms and techniques
Challenges in ADC bioanalysis
Guidelines and strategies for biomarker bioanalysis
